Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: The Effectiveness of Early Immunisation With Nirsevimab on Preschool Wheezing in France, Based on an Analysis of Data From the French Health System Database.

View source ↗

Summary

This clinical trial protocol evaluates whether early immunisation with Nirsevimab reduces preschool wheezing in France, using data from the French Health System…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BEYFORTUS (Nirsevimab)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Infant Wheeze, Preschool Age Children | Status: NOT_YET_RECRUITING